Precision Medicine

City of Hope and Adagene Launch Trial for Colorectal Cancer
Research & Development City of Hope and Adagene Launch Trial for Colorectal Cancer

Advancing Immunotherapy in the Global Oncology Landscape The current trajectory of global oncology research is defined by a rigorous departure from generalist treatments toward sophisticated, molecularly targeted therapies that prioritize long-term patient survival over temporary remission. In

Nigerian Breast Cancer Patients Ready for Genetic Testing
Research & Development Nigerian Breast Cancer Patients Ready for Genetic Testing

While approximately 95.7 percent of Nigerian breast cancer patients express readiness for genetic testing, the vast majority have a mean correct response rate of only 20.5 percent regarding recognized risk factors. The epidemiological landscape of Nigeria has undergone a profound transformation as

Isomorphic Labs Secures Five Billion Dollars for AI Drug Design
Tech & Innovation Isomorphic Labs Secures Five Billion Dollars for AI Drug Design

The pharmaceutical industry has long grappled with the 'Eroom’s Law' phenomenon, where the cost of developing a new drug doubles approximately every nine years despite major technological advances, making the quest for efficiency a matter of global health survival. This struggle has reached a

Closing the Equity Gap in Cancer Care Through Precision Medicine
Tech & Innovation Closing the Equity Gap in Cancer Care Through Precision Medicine

Legislative progress in 25 states has mandated biomarker testing coverage, yet many patients still face prohibitive cost-sharing requirements and frequent insurance denials for innovative modalities. The promise of precision medicine—the tailoring of medical treatment to the individual

New Study Identifies DAMA Rat Model as High-Fidelity TNBC Surrogate
Research & Development New Study Identifies DAMA Rat Model as High-Fidelity TNBC Surrogate

Recent findings demonstrate that systemic methotrexate treatment exerts selective pressure on the DAMA genome, leading to significant increases in Myc and Kras mutation frequencies. This discovery marks a pivotal moment in 2026 for the oncology community, which has long struggled to find

Can Selenium Nanoparticles Revolutionize Precision Medicine?
Research & Development Can Selenium Nanoparticles Revolutionize Precision Medicine?

High-dose selenium can act as a specific inducer of ferroptosis in lung cancer cells, triggering a regulated, iron-dependent cell death that suppresses tumor growth. This discovery highlights the paradoxical nature of a trace element that is simultaneously indispensable and potentially lethal. For

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later